We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Recognizing that industry interest in using nanotechnology in drug development and delivery is on the rise, the FDA will hold a public workshop in mid-October to learn about products under development in drugs and biologics, as well as other areas.
The size of the market for eclinical trials was $210 million in 2004 and will increase to $357.4 million in 2011, according to a new report published by consulting firm Frost & Sullivan.
It is better under a majority of objective measures to use high frequency (HF) rather than ultra-high frequency (UHF) radio frequency identification (RFID) tags on individual pharmaceutical items such as pill bottles, according to a recent research paper.
High frequency (HF) radio frequency identification (RFID) tags are preferable to their ultra-high frequency (UHF) counterparts in combating counterfeiting or diversion of pharmaceutical products, a new study finds.
Decreasing reimbursement rates have forced healthcare providers and manufacturers to cut costs and increase the lifetime of oxygen therapy devices, according to a Frost & Sullivan survey.
It is often said the pharma industry has lagged behind others in converting from paper-based recordkeeping, notably in clinical trials, to an all-electronic environment.
In an effort to protect patients from counterfeit products, GlaxoSmithKline (GSK) has attached radio frequency identification (RFID) tags to all bottles of its HIV treatment Trizivir distributed in the U.S.